The recent instability in global chains have highlighted the value of securing essential medications like Ivermectin. Relying on overseas manufacturers exposes countries to potential vulnerabilities, including shipping delays, expense fluctuations, and even trade concerns. Moving towards domestic sourcing of Ivermectin offers a multitude of advanta